U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
192061192061A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1Active, not recruitingNo Results AvailableSubstance-Related DisordersBehavioral: Behavior Therapyhttps://ClinicalTrials.gov/show/NCT00033124
192062192062A Study of Cabergoline for the Treatment of Cocaine Dependence - 1CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Cabergolinehttps://ClinicalTrials.gov/show/NCT00033111
192063192063Cocaine-Metyrapone Interaction Study - 1Active, not recruitingNo Results AvailableCocaine-Related Disorders|Infusions, IntravenousDrug: Metyraponehttps://ClinicalTrials.gov/show/NCT00033098
192064192064Ondansetron for the Treatment of Cocaine Dependence - 1CompletedNo Results AvailableCocaine-Related Disorders|Drug Administration ScheduleDrug: Ondansetronhttps://ClinicalTrials.gov/show/NCT00033085
192065192065Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Active, not recruitingNo Results AvailableAmphetamine-Related DisordersDrug: Selegilinehttps://ClinicalTrials.gov/show/NCT00033072
192066192066Assessment of Potential Interactions Between Cocaine and Tolcapone - 1Active, not recruitingNo Results AvailableCocaine-Related DisordersDrug: Tolcaponehttps://ClinicalTrials.gov/show/NCT00033059
192067192067Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1Active, not recruitingNo Results AvailableCocaine-Related Disorders|Drug Administration Schedule|Infusions, IntravenousDrug: Modafinilhttps://ClinicalTrials.gov/show/NCT00033046
192068192068Reserpine for the Treatment of Cocaine Dependence - 1CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Reserpinehttps://ClinicalTrials.gov/show/NCT00033033
192069192069Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1CompletedNo Results AvailableSubstance-Related DisordersBehavioral: Behavior Therapyhttps://ClinicalTrials.gov/show/NCT00033020
192070192070Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1CompletedNo Results AvailableSubstance-Related DisordersBehavioral: Behavior Therapyhttps://ClinicalTrials.gov/show/NCT00033007
192071192071Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1CompletedNo Results AvailableSubstance-Related DisordersBehavioral: Behavior Therapyhttps://ClinicalTrials.gov/show/NCT00032994
192072192072Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1CompletedNo Results AvailableSubstance-Related DisordersBehavioral: Behavior Therapyhttps://ClinicalTrials.gov/show/NCT00032981
192073192073Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1CompletedNo Results AvailableHeroin Dependence|Morphine Dependence|Substance Withdrawal SyndromeDrug: Buprenorphine/naloxonehttps://ClinicalTrials.gov/show/NCT00032968
192074192074Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1CompletedNo Results AvailableHeroin Dependence|Morphine Dependence|Substance Withdrawal SyndromeDrug: Buprenorphine/naloxonehttps://ClinicalTrials.gov/show/NCT00032955
192075192075Lofexidine for Opiate Withdrawal - 1CompletedNo Results AvailableOpioid-Related DisordersDrug: Lofexidinehttps://ClinicalTrials.gov/show/NCT00032942
192076192076Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedNo Results AvailableCocaine-Related DisordersDrug: Selegilinehttps://ClinicalTrials.gov/show/NCT00032929
192077192077Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1Active, not recruitingNo Results AvailableCocaine-Related Disorders|Drug Administration Schedule|Infusions, IntravenousDrug: NS2359https://ClinicalTrials.gov/show/NCT00032916
192078192078This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.CompletedNo Results AvailableMalignant GliomaDrug: Gimatecan® (ST 1481)https://ClinicalTrials.gov/show/NCT00032903
192079192079Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)CompletedNo Results AvailableOsteoarthritisDrug: glucosamine|Drug: chondroitin sulfate|Drug: glucosamine and chondroitin sulfate combined|Drug: celecoxibhttps://ClinicalTrials.gov/show/NCT00032890
192080192080Genetic Analysis of Fraser Syndrome and Fryns SyndromeCompletedNo Results AvailableFraser Syndrome|Fryns Syndrome|Chromosomal Abnormalities|Abnormalities, Multiplehttps://ClinicalTrials.gov/show/NCT00032877
192081192081Clinical Trial of Footwear in Patients With DiabetesCompletedNo Results AvailableAmputations|Diabetes|Lower Extremity Ulcershttps://ClinicalTrials.gov/show/NCT00032864
192082192082Effects of Stress Hormones on Emotion and CognitionCompletedNo Results AvailableHealthyDrug: Yohimbinehttps://ClinicalTrials.gov/show/NCT00032838
192083192083Ketoconazole Plus Docetaxel to Treat Prostate CancerCompletedNo Results AvailableProstatic NeoplasmsDrug: Ketaconazole|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00032825
192084192084The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's DiseaseCompletedNo Results AvailableParkinson Disease|HealthyDrug: Raclopridehttps://ClinicalTrials.gov/show/NCT00032812
192085192085Safety and Efficacy of Natalizumab in the Treatment of Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: natalizumabhttps://ClinicalTrials.gov/show/NCT00032799
192086192086Safety and Efficacy of Natalizumab in the Treatment of Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: natalizumabhttps://ClinicalTrials.gov/show/NCT00032786
192087192087Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHDTerminatedNo Results AvailableAcute Graft Versus Host DiseaseDrug: pentostatin for injectionhttps://ClinicalTrials.gov/show/NCT00032773
192088192088Meditation-Based Treatment for Binge Eating DisorderCompletedNo Results AvailableBinge Eating Disorder|ObesityBehavioral: Meditationhttps://ClinicalTrials.gov/show/NCT00032760
192089192089Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).CompletedNo Results AvailableChronic Heart FailureDrug: Vasopressin V2 Receptor Antagonisthttps://ClinicalTrials.gov/show/NCT00032747
192090192090Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedNo Results AvailableSyndrome of Inappropriate ADH (SIADH) Secretion|HyponatremiaDrug: satavaptan (SR121463B)https://ClinicalTrials.gov/show/NCT00032734

* Görseller ve İçerik tekif hakkına sahip olabilir